Activity of inhaled lysine acetylsalicylate (L-ASA) on bradykinin-induced bronchoconstriction in asthmatics: Evidence of contribution of prostaglandins

European Respiratory Journal

Volumn 10, Issue 4, 1997, Pages 866-871

  Polosa, R ^a   Milazzo, V L ^a   Magri S ^a   Pagano, C ^a   Paolino, G ^a   Santonocito, G ^a   Prosperini, G ^a   Crimi, N ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Asthma; Bradykinin; Bronchoconstriction; Lysine acetylsalicylate

Indexed keywords

ACETYLSALICYLIC ACID; BRADYKININ; LYSINE ACETYLSALICYLATE; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADULT; AIRWAY RESISTANCE; ANALYSIS OF VARIANCE; ASPIRIN; ASTHMA; BRADYKININ; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LYSINE; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; PROSTAGLANDINS;

EID: 0030891282     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Polosa R. Role of the kinin-kallikrein pathway in allergic diseases. Allergy 1993; 48: 217-225.
2. Liu MC, Hubbard WC, Proud D, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator and permeability changes. Am Rev Respir Dis 1991; 144: 51-58.
3. Christiansen SC, Proud D, Sarnolf RB, Juergens U, Cochrane CG, Zuraw BL. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis 1992; 145: 900-905.
4. Sana A, Lundberg JM, Skofitsch G, Lembeck F. Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn Sch Arch Pharmacol 1983; 324: 212-218.
5. Laitinen LA, Laitinen A, Widdicombe JG. Effects of inflammatory and other mediators on airway vascular beds. Am Rev Respir Dis 1987; 135: 567-570.
6. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ. Bradykinin-induced bronchoconstriction in humans: mode of action. Am Rev Respir Dis 1987; 135: 176-180.
7. 9]-bradykinin in normal and asthmatic subjects. Am Rev Respir Dis 1990; 142: 1367-1371.
8. Kaufman MP, Coleridge HM, Coleridge JCG, Baker DG. Bradykinin stimulates afferent vagal C-fibers in intrapulmonaly airways in dogs. J Appl Physiol: Respirat Environ Exercise Physiol 1980; 48: 511-517.
9. Miura M, Belvisi MG, Barnes PJ. Effect of bradykinin on airway neural responses in vitro. J Appl Physiol 1992; 73: 1537-1541.
10. Soler M, Sielczak M, Abraham WM. A bradykinin antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulm Pharmacol 1990; 3: 9-15.
11. Polosa R, Rajakulasingam K, Prosperini G, et al. Effect of inhaled bradykinin on indices of airway responsiveness in asthmatic subjects. Eur Respir J 1994; 7: 1490-1496.
12. Polosa R, Phillips GD, Lai CKW, Holgate ST. Contribution of histamine and prostanoids to bronchoconstriction provoked by inhaled bradykinin in atopic asthma. Allergy 1990; 45: 174-182.
13. Polosa R, Lai CKW, Robinson C, Holgate ST. The influence of cyclo-oxygenase inhibition on the loss of bronchoconstrictor response to repeated bradykinin challenge in asthma. Eur Respir J 1990; 3: 914-921.
14. Bianco S, Vaghi A, Pieroni MG, Robuschi M, Refini RM, Sestini P. Protective activity of inhaled nonsteroidal anti-inflammatory drugs on bronchial responsiveness to ultrasonically nebulized water. J Allergy Clin Immunol 1992; 90: 833-839.
15. Bianco S, Vaghi A, Pieroni MG, et al. Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate. Allergy 1993; 48: 570-575.
16. Climi N, Polosa R, Prosperini G, Magrì S, Ciamarra I, Mistretta A. Changes in NKA airway responsiveness with inhaled lysine-acetylsalicylate in asthma. Eur Respir J 1996; 9: 1139-1145.
17. Crimi N, Polosa R, Magrì S, et al. Inhaled L-ASA attenuates the bronchoconstrictor response to AMP in asthmatic subjects. Eur Respir J 1995; 8: 905-912.
18. Lewis RA. Therapeutic aerosols. In: Cumming G, Bonsignore C, eds. Drugs and the Lung. London, Plenum Publishing Co., 1984; pp. 63-86.
19. Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323-327.
20. Altman DG, Bland JH. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 8: 307-310.
21. Crook D, Collins AJ, Rose AJ. A comparison of the effect of flurbiprofen on prostaglandin synthetase from human rheumatoid synovium and enzymatically active animal tissues (Abstract). J Pharm Pharmacol 1976; 28: 535.
22. Fish JE, Ankin MG, Adkinson NF, Peterman VI. Indomethacin modification of the immediate-type immunologic airway responses in allergic, asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1981; 123: 609-614.
23. Sterk PJ, Daniel EE, Zamel N, Hargreave FE. Limited maximal airway narrowing in nonasthmatic subjects: role of neural control and prostaglandin release. Am Rev Respir Dis 1985; 132: 865-870.
24. Campbell AM, Robinson C. Further studies on IgE-mediated eicosanoid release from human dispersed lung cells (Abstract), Br J Pharmacol 1988; 95: 674.
25. Regoli D, Barabe J. Pharmacology of bradykinin and related peptides. Pharmacol Rev 1980; 31: 1-46.
26. 2 generation and the effect of aspirin. Prostaglandins 1980; 20: 547-557.
27. Bramley AM, Samhoun MN, Piper PJ. The role of the epithelium in modulating the responses of guinea-pig trachea induced by bradykinin in vitro. Br J Pharmacol 1990; 99: 762-766.
28. Ishizaka T, Iwata M, Ishizaka K. Release of histamine and arachidonate from mouse mast cells induced by glycosylation-enhancing factor and bradykinin. J Immunol 1985; 134: 1880-1887.
29. Molimard M, Martin CAE, Naline E, Hirsch A, Advenier C. Contractile effects of bradykinin on the isolated human small bronchus. Am J Respir Crit Care Med 1994; 149: 123-127.
30. Hulsmann AR, Raatgeep HR, Saxena PR, Kerrebijn KF, de Jongste JC. Bradykinin-induced contraction of human peripheral airways mediated by both B2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med 1994; 150: 1012-1018.
31. Church MK, Polosa R, Rimmer SJ. Cromolyn sodium and nedocromil sodium: mast cell stabilizers, neuromodulators or anti-inflammatory drugs? In: Kaliner MA, Barnes PJ, Persson CGA, eds. Asthma: its Pathology and Treatment. New York, Marcel Dekker, 1991; 561-593.
32. Dixon CMS, Barnes PJ. Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1989; 27: 831-836.
33. Rajakulasingam K, Polosa R, Church MK, Howarth PH, Holgate ST. Effect of inhaled frusemide on responses of airways to bradykinin and adenosine 5'-monophosphate in asthma. Thorax 1994; 49: 485-491.
34. Maggi CA, Meli A. The sensory efferent function of capsaicin-sensitive sensory neurones. Gen Pharmacol 1988; 19(1): 1-43.
35. Crimi N, Polosa R, Maccarrone C, Palermo B, Palermo F, Mistretta A. Effect of topical application with capsaicin on skin responses to bradykinin and histamine in man. Clin Exp Allergy 1992; 22: 933-939.
36. Ichinose M, Nahajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 1992; 340: 1248-1251.
37. Russell JA. Substance P elicits thromboxane-induced contraction of canine pulmonary veins. Pulm Pharmacol 1988; 1: 153-159.
38. Selig WM, Burhop KE, Garcia JGN, Malik AB. Substance P induced pulmonary vasoreactivity in isolated perfused guinea-pig lung. Circ Res 1988; 62: 196-203.
39. Frossard N, Rhoden KJ, Barnes PJ. Influence of epithelium on guinea-pig airway responses to tachykinins: role of endopeptidase and cyclo-oxygenase. J Pharmacol Exp Ther 1989; 248: 292-298.